Invention Grant
US08258151B2 3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors
失效
3-氨基咪唑并[1,2-A]吡啶衍生物作为SGLT抑制剂
![3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors](/docs/US/2012-09-04/US08258151B2/abs.jpg.600x600.jpg)
- Patent Title: 3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors
- Patent Title (中): 3-氨基咪唑并[1,2-A]吡啶衍生物作为SGLT抑制剂
-
Application No.: US12305744Application Date: 2007-05-25
-
Publication No.: US08258151B2Publication Date: 2012-09-04
- Inventor: Werner Mederski , Norbert Beier , Bertram Cezanne , Rolf Gericke , Markus Klein , Christos Tsaklakidis
- Applicant: Werner Mederski , Norbert Beier , Bertram Cezanne , Rolf Gericke , Markus Klein , Christos Tsaklakidis
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102006028862 20060623
- International Application: PCT/EP2007/004674 WO 20070525
- International Announcement: WO2007/147478 WO 20071227
- Main IPC: A01N47/00
- IPC: A01N47/00 ; A61K31/21
![3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors](/abs-image/US/2012/09/04/US08258151B2/abs.jpg.150x150.jpg)
Abstract:
Novel compounds of the formula I, in which X, Y, R, R′, R1, R1′, R1″, R2, R2′, R2″, R3, R3′, R4, R4′ and n have the meanings indicated in Patent Claim 1, are suitable as antidiabetics
Public/Granted literature
- US20110195991A1 3-AMINOIMIDAZO [1,2-A] PYRIDINE DERIVATIVES AS SGLT INHIBITORS Public/Granted day:2011-08-11
Information query
